To further elucidate the relationship between miR-29s expression levels and TP53/SETDB1 expression levels in primary NSCLC samples, we first detected TP53 and SETDB1 mRNA expression in clinical tissues. This evidence concerns the gene SETDB1 and non-small cell lung carcinoma.